Page 7 - Quotient Sciences News Today

Scientists said that if the pill can be used widely it will transform contraception.

Scientists said that if the pill can be used widely it will transform contraception.

Scientists said that if the pill can be used widely it will transform contraception.

Scientists said that if the pill can be used widely it will transform contraception.

Scientists said that if the pill can be used widely it will transform contraception.

Scientists said that if the pill can be used widely it will transform contraception.

Unlike the female pill, a new male equivalent, YCT-529, is hormone-free and prevents sperm production by blocking access to vitamin A. If the tests prove successful, scientists hope the responsibility for contraception could be shared between the sexes.

Launching a company based on knowledge that “the fundamental principle that most people hold to be true is off by a trillion” is a rare opportunity, said Jake Rubens, co-founder and president of Quotient Therapeutics Inc., a company that emerged from stealth this week, backed by two years of platform development and a $50 million investment from Flagship Pioneering.

Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The

/PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet...